IL6 and Hepatic fibrosis: In a severe liver fibrosis model, treatment with cRLN2 not only effectively alleviated fibrosis but also restored the normal levels of inflammatory cytokine in serum (IFN-α, TNF-α, and IL-6) (Figure 2D).